Drug Profile
Ritonavir - AbbVie
Alternative Names: A 84538; ABT 538; NorvirLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Developer AbbVie; Gilead Sciences; RP Scherer
- Class Amides; Antiretrovirals; Carbamates; Small molecules; Thiazoles
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed HIV infections; HIV-1 infections